Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1897 1
1898 1
1928 2
1934 1
1935 1
1938 1
1940 1
1945 30
1946 90
1947 97
1948 118
1949 119
1950 130
1951 207
1952 214
1953 229
1954 234
1955 253
1956 206
1957 254
1958 237
1959 225
1960 256
1961 304
1962 301
1963 457
1964 570
1965 361
1966 363
1967 441
1968 443
1969 504
1970 466
1971 533
1972 511
1973 467
1974 527
1975 546
1976 525
1977 550
1978 580
1979 687
1980 631
1981 766
1982 820
1983 900
1984 1032
1985 1142
1986 1086
1987 1126
1988 1205
1989 1458
1990 1496
1991 1344
1992 1563
1993 1808
1994 1847
1995 1814
1996 1881
1997 1957
1998 1985
1999 2104
2000 2241
2001 2367
2002 2382
2003 2656
2004 2880
2005 3015
2006 3326
2007 3450
2008 3509
2009 3844
2010 4073
2011 4443
2012 4804
2013 4976
2014 5374
2015 5696
2016 5768
2017 5757
2018 5815
2019 6305
2020 6748
2021 1511
Text availability
Article attribute
Article type
Publication date

Search Results

122,084 results
Results by year
Filters applied: . Clear all
Page 1
Epidemiology of epithelial ovarian cancer.
Webb PM, Jordan SJ. Webb PM, et al. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14. doi: 10.1016/j.bpobgyn.2016.08.006. Epub 2016 Oct 3. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27743768 Review.
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer death, with five-year survival rates below 45%. ...We will also briefly review the relationship between lifestyle and survival after a diagno …
Globally, ovarian cancer is the seventh most common cancer in women and the eighth most common cause of cancer d …
Ovarian Cancer: An Integrated Review.
Stewart C, Ralyea C, Lockwood S. Stewart C, et al. Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11. Semin Oncol Nurs. 2019. PMID: 30867104 Review.
This article will also examine current and future clinical trials surrounding ovarian cancer. DATA SOURCES: A review of articles dated 2006-2018 from CINAHL, UpToDate, and National Comprehensive Cancer Network guidelines. ...Although advances are being made, …
This article will also examine current and future clinical trials surrounding ovarian cancer. DATA SOURCES: A review of articl …
Ovarian cancer: an overview.
Roett MA, Evans P. Roett MA, et al. Am Fam Physician. 2009 Sep 15;80(6):609-16. Am Fam Physician. 2009. PMID: 19817326 Free article. Review.
Although ovarian cancer may occur at any age, it is more common in patients older than 50 years. ...Epithelial ovarian cancer is the most common type of ovarian cancer, and because 70 percent of cases are diagnosed at stage III or IV, it …
Although ovarian cancer may occur at any age, it is more common in patients older than 50 years. ...Epithelial ovarian
[Ovarian cancer--from biology to clinic].
Kujawa KA, Lisowska KM. Kujawa KA, et al. Postepy Hig Med Dosw (Online). 2015 Dec 2;69:1275-90. doi: 10.5604/17322693.1184451. Postepy Hig Med Dosw (Online). 2015. PMID: 26671919 Free article. Review. Polish.
Ovarian cancer is the most frequent cause of deaths from among gynecologic malignancies. ...These new findings will have an impact on diagnostic approaches as well as on the prevention options for women with genetic predisposition to ovarian cancer. Th
Ovarian cancer is the most frequent cause of deaths from among gynecologic malignancies. ...These new findings will have an im
Ovarian Cancer: A Heterogeneous Disease.
Kossaï M, Leary A, Scoazec JY, Genestie C. Kossaï M, et al. Pathobiology. 2018;85(1-2):41-49. doi: 10.1159/000479006. Epub 2017 Oct 12. Pathobiology. 2018. PMID: 29020678 Free article.
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes, these are treated as a single disease. Tremendous efforts have
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and progn
Real-world evidence in the treatment of ovarian cancer.
Eisenhauer EA. Eisenhauer EA. Ann Oncol. 2017 Nov 1;28(suppl_8):viii61-viii65. doi: 10.1093/annonc/mdx443. Ann Oncol. 2017. PMID: 29232466 Free article. Review.
In addition, literature and international cancer registry trends in ovarian cancer survival, mortality and incidence rates were compiled. ...CONCLUSIONS: There are few RWE studies of specific treatments in ovarian cancer. Trends in relative surv …
In addition, literature and international cancer registry trends in ovarian cancer survival, mortality and incidence ra …
Ovarian cancer stem cells more questions than answers.
Ottevanger PB. Ottevanger PB. Semin Cancer Biol. 2017 Jun;44:67-71. doi: 10.1016/j.semcancer.2017.04.009. Epub 2017 Apr 24. Semin Cancer Biol. 2017. PMID: 28450177 Free article. Review.
Ovarian cancer either develops from the ovarian surface epithelium (OSE) or from serous intra-epithelial carcinoma (STIC). ...However the knowledge of ovarian cancer stem cells (OCSC) and the role they play in the development of cancer an
Ovarian cancer either develops from the ovarian surface epithelium (OSE) or from serous intra-epithelial carcinoma (STI
Can advanced-stage ovarian cancer be cured?
Narod S. Narod S. Nat Rev Clin Oncol. 2016 Apr;13(4):255-61. doi: 10.1038/nrclinonc.2015.224. Epub 2016 Jan 20. Nat Rev Clin Oncol. 2016. PMID: 26787282 Review.
Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cured. Initial therapy for ovarian cancer comprises surgery and chemotherapy, and is given with the goal of eradicating as many …
Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cure …
Ovarian cancer: risk factors, treatment and management.
Rooth C. Rooth C. Br J Nurs. 2013 Sep 12-25;22(17):S23-30. doi: 10.12968/bjon.2013.22.Sup17.S23. Br J Nurs. 2013. PMID: 24067270 Review.
Ovarian cancer is the fifth most common cancer affecting women in the UK today, with associated statistics illustrating a steadily increasing rate, particularly in women aged 65 and over (Cancer Research UK, 2013). ...New treatments such as bevacizumab
Ovarian cancer is the fifth most common cancer affecting women in the UK today, with associated statistics illustrating
Targeted Therapies for Ovarian Cancer.
Grunewald T, Ledermann JA. Grunewald T, et al. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:139-152. doi: 10.1016/j.bpobgyn.2016.12.001. Epub 2016 Dec 8. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 28111228 Review.
Epithelial ovarian cancer has the highest mortality rate of all gynaecological malignancies. ...Many of these innovative approaches already demonstrate promising activity in ovarian cancer and have the potential to improve the outcome in women with …
Epithelial ovarian cancer has the highest mortality rate of all gynaecological malignancies. ...Many of these innovative appro …
122,084 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page